June 2015 Blog Posts (3)

Preclinical Data Demonstrated Superiority of BTP-114 to Cisplatin in Tumor Growth Inhibition

Data from preclinical research presented in a poster at annual meeting of the American Association for Cancer Research (AACR) being held April 18 - 22, 2015 in, Philadelpphia, PA, demonstrates that BTP-114, a novel, personalized cisplatin prodrug being developed by Blend Therapeutics, Inc. (Watertown, MA 02472), a biopharmaceutical company discovering and developing two distinct classes of…

Continue

Added by Editorial Team on June 30, 2015 at 6:00pm — No Comments

Almac Diagnostocs and OncoMed Pharmaceuticals Enter in Companion Diagnostic Partnership

To help predict the likelihood that patients will respond to certain anti-cancer drugs, so-called companion diagnostics have been developed. In late June, Almac Diagnostics entered into an agreement with OncoMed Pharmaceuticals, Inc. a clinical-stage company focused on discovering and developing novel therapeutics targeting cancer stem cells (CSCs). The purpose of the collaboration is…

Continue

Added by Editorial Team on June 23, 2015 at 11:00am — No Comments

Is the Glass Half Full or Half Empty for Health Plans?

By Paul Keckley, Ph.D., Navigant Healthcare

Last week, approximately 1,000 people convened in Nashville for the 2015 America’s Health Insurance Plans Institute (AHIP,…

Continue

Added by Editorial Team on June 8, 2015 at 12:30pm — No Comments

Monthly Archives

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2005

2004

2001

Register for free to view all the Onco'Zine - The International Oncology Network content:

ADVERTISEMENT/MEDIA PARTNER

Onco'Zine is present here

Bookmark / Share

CONNECT WITH US AND

JOIN THE CONVERSATION


© 2017   Created by Peter Hofland, PhD.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+